|
Mesothelioma Chemotherapy Journal Articles
Cytoreductive
surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
Single-agent
pemetrexed for chemonaïve and pretreated patients with malignant pleural
mesothelioma: results of an International Expanded Access Program.
Cisplatin
and vinorelbine first-line chemotherapy in non-resectable malignant
pleural mesothelioma
Active
symptom control with or without chemotherapy in the treatment of patients
with malignant pleural mesothelioma (MS01): a multicentre randomised
trial
Molecular
analysis of the effects of Piroxicam and Cisplatin on mesothelioma
cells growth and viability
Malignant
Mesothelioma Continues to Present a Difficult Therapeutic Target
- ASCO report
Piroxicam
and intracavitary platinum-based chemotherapy for the treatment of
advanced mesothelioma in pets: preliminary observations
Homocysteine and Methylmalonic Acid: Markers
to Predict and Avoid Toxicity from Pemetrexed Therapy
Effective therapy of human lymphoma xenografts
with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody
immunotoxin.
Survival
and relapse pattern after trimodality therapy for malignant pleural
mesothelioma.
Many experts say that germs have the ability to make the body adjust
and learn about the fighting back mechanism against tumors.
If you have mesothelioma,
we might be able to help you. Fill out this form.
This website is sponsored by Jonathan David* of The
David Law Firm. The David Law Firm is located in The Woodlands, Texas
(Greater Houston Area) and can be reached toll free at 1-800-998-9729
for more information on mesothelioma. Jonathan David is not a medical
doctor. The information on these pages is for the education of mesothelioma
patients and their families regarding potential medical and legal
options. Patients are advised to consult with a medical doctor.
* Licensed
by the Supreme Court of Texas.
|
